Santé log8h
Scarless MTF Breast Augmentation Performed by Seattle Plastic Surgeon
Recognizing affordability as essential, Dr. Sajan accepts all private insurance plans for MTF breast augmentation, significantly reducing financial barriers. Patients using insurance typically pay ...
Santé log14h
Arialief Reviews (SHOCKING REPORT!) Is This Sciatic Nerve Relief Supplement Safe or Overhyped Hoax?
The supplement is one of the sciatic discomfort relief formulas that has been launched recently. Though it claims to be ...
Santé log16h
INFERTILITÉ : Quand c'est l’ocytocine qui impose une pause
Accèdez sans limite aux 15 000 actualités du site et recevez gratuitement chaque semaine, la Newsletter Santé log avec les ...
Santé log23h
PacBio Grants Equity Incentive Award to New Employee
The Option has an exercise price of $1.18 per share, which is equal to the closing price of PacBio common stock on March 31, 2025 (the “Effective Date”). The shares subject to the Option are scheduled ...
Santé log1d
Breaking Barriers in Autism: European Wellness Biomedical Group Unveils Bioregenerative Breakthroughs with Prof. Mike Chan
Prof. Mike Chan’s lifelong dedication to autism treatment is transforming the landscape of bioregenerative medicine. His ...
Santé log1d
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
About Syndax Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company's pipeline include Revuforj ® ...
Santé log1d
AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal
Additional details are included in, and the description above is qualified in its entirety by, AIM’s Current Report on Form 8-K filed with the SEC on April 4, 2025, which will be made available under ...
Santé log1d
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The stock options are subject to the terms and conditions of Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan, as well as the terms and conditions of the stock option agreement covering the ...
Santé log1d
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of ...
Santé log1d
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted an inducement award consisting of non-qualified stock options to ...
Santé log1d
Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger
Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients ...
Santé log1d
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of ...